-
The United States Department of Agriculture (USDA) Dietary Guidelines for Americans 2005 states: "Compared with the many people who consume a dietary pattern with only small amounts of fruits and vegetables, those who eat more generous amounts as part of a healthful diet are likely to have reduced risk of chronic diseases, including stroke and perhaps other cardiovascular diseases, type 2 diabetes, and cancers in certain sites [oral cavity and pharynx, larynx, lung, esophagus, stomach, and colon-rectum]. Diets rich in foods containing fiber, such as fruits, ... may reduce the risk of coronary heart disease."
-
Goal: To explore via fMRI the neuronal pathways potentially involved in acupuncture's effects on salivary flow.
-
Strategies to determine treatment of acute coronary syndromes need to take gender into account.
-
Lifestyle changes plus red yeast rice and fish oil resulted in similar beneficial effects on LDL cholesterol as moderate-dose statin therapy in patients meeting criteria for drug therapy for high LDL cholesterol.
-
Optimizing medical and lifestyle change therapy rather than performing PCI is appropriate as the initial management strategy for most patients with known CAD who do not have unstable or disabling symptoms.
-
-
A randomized controlled trial in the Netherlands showed that oral prednisolone and naproxen were equivalent in the treatment of acute gout with no difference in side effects.
-
Using blood pressure, BUN, serum sodium, and presence of peripheral arterial disease as predictors of mortality in heart failure patients, 67% who had 3 or more factors died within 6 months and would qualify for the Medicare hospice benefit.
-
There are no disease-modifying pharmacotherapies for COPD. That is, although bronchodilators, anticholinergic agents, and inhaled corticosteroids improve FEV1 and reduce symptoms, decline in pulmonary function continues unabated and lung function returns promptly to pretreatment status once medication is stopped.
-
Although Enzyme-Immunoassay (EIA) tests have replaced cytotoxin assays for diagnosis of Clostridium difficile-associated diarrhea (CDAD) in most US laboratories, the changing epidemiology of this disease suggests that an adjustment in diagnostic testing algorithms is needed.
